Altimmune to Participate in the Wells Fargo 21st Annual Healthcare Conference
Altimmune management will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Thursday, September 10, 2026, at 9:30 a.m. ET. A webcast of the session will be available through the Events section of the Altimmune website. Altimmune is a late clinical-stage biopharmaceutical company developing pemvidutide, a dual glucagon/GLP-1 receptor therapy, for MASH, alcohol use disorder, and alcohol-associated liver disease.
Key figures
- Conference
- Wells Fargo 21st Annual Healthcare Conference
- Webcast available
- Yes
- Fireside chat datetime
- 2026-09-10T09:30:00-04:00
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.